subject: UNII:52CMI0WC3Y

object_name: Stage IV Lung Cancer AJCC v6


subject: UMLS:C3827082

object_name: Stage IV Lung Cancer AJCC v7

tested_intervention: unsure


subject: UMLS:C3827082


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:4911

subject_name: Etoposide

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Burkitt lymphoma


subject: CHEBI:229221

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:229221

object_name: Adult Burkitt Lymphoma


subject: CHEBI:229221

object_name: Hodgkin Disease


subject: CHEBI:229221

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:229221

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:229221

object_name: follicular lymphoma


subject: CHEBI:229221

object_name: diffuse large B-cell lymphoma


subject: CHEBI:229221

object_name: Hormone Receptor-Positive Breast Carcinoma

tested_intervention: yes


subject: CHEBI:229221

object_name: head and neck squamous cell carcinoma


subject: CHEBI:229221

object_name: triple-negative breast carcinoma


subject: CHEBI:229221

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:229221

object_name: skin squamous cell carcinoma


subject: CHEBI:229221

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:229221

object_name: non-small cell lung carcinoma


subject: CHEBI:229221

object_name: small intestine cancer


subject: CHEBI:229221

object_name: small intestine carcinoma


subject: CHEBI:229221

object_name: carcinoma of esophagus


subject: CHEBI:229221

object_name: esophageal cancer


subject: CHEBI:229221

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:229221

object_name: neoplasm of esophagus


subject: UMLS:C5854434

subject_name: Rezorstobart

object_name: Burkitt lymphoma


subject: UMLS:C5854434

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C5854434

object_name: Adult Burkitt Lymphoma


subject: UMLS:C5854434

object_name: Hodgkin Disease


subject: UMLS:C5854434

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5854434

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5854434

object_name: follicular lymphoma


subject: UMLS:C5854434

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5854434

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C5854434

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5854434

object_name: triple-negative breast carcinoma


subject: UMLS:C5854434

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5854434

object_name: skin squamous cell carcinoma


subject: UMLS:C5854434

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5854434

object_name: non-small cell lung carcinoma


subject: UMLS:C5854434

object_name: small intestine cancer


subject: UMLS:C5854434

object_name: small intestine carcinoma


subject: UMLS:C5854434

object_name: colorectal cancer


subject: UMLS:C5854434

object_name: colorectal carcinoma


subject: UMLS:C5854434

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854434

object_name: carcinoma of esophagus


subject: UMLS:C5854434

object_name: esophageal cancer


subject: UMLS:C5854434

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854434

object_name: neoplasm of esophagus


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Adult-onset immunodeficiency


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:185135

subject_name: Polyvidone

object_name: Wound Infection


subject: CHEBI:185135

object_name: Wound Infection, CTCAE


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8347


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Fatigue, CTCAE 5.0


subject: PUBCHEM.COMPOUND:21873174

object_name: Fatigue


subject: PUBCHEM.COMPOUND:21873174

object_name: multiple sclerosis


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:78538

object_name: Transthyretin amyloid cardiomyopathy


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: Irritable heart


subject: CHEBI:127342

object_name: neurocirculatory asthenia


subject: CHEBI:132082

subject_name: Entinostat

object_name: neuroendocrine neoplasm


subject: UMLS:C5814270

object_name: atopic eczema


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Vasomotor disturbance


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:9904258

object_name: disorder of aging


subject: UMLS:C4310518

subject_name: Zebinix

object_name: epilepsy


subject: UMLS:C4310518


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Immunosuppression


subject: UMLS:C0003442

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0003442

object_name: hepatobiliary disorder


subject: UMLS:C0003442

object_name: liver disorder


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: UMLS:C1562036

subject_name: Calcineurin inhibitor

object_name: graft versus host disease


subject: UMLS:C5239440


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:71954

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:71954

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:71954

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:39585

subject_name: Carbidopa

object_name: multiple sclerosis


subject: CHEBI:66964

subject_name: Dronabinol


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:58097

object_name: Cardiac Output


subject: CHEBI:58097

object_name: cardiac catheterization cardiac output in liters per minute


subject: CHEBI:58097

object_name: pneumonectomy; status


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:73005958

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:73005958

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:73005958

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:73005958

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:73005958

object_name: kidney cancer


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:64312

subject_name: Memantine

object_name: Battery (assault)


subject: UMLS:C0595531

subject_name: Menopur

object_name: hypogonadotropic hypogonadism


subject: UMLS:C0595531

object_name: Klinefelter syndrome


subject: MESH:C551396

subject_name: pergoveris


subject: MESH:C551396


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: schizophrenia


subject: CHEBI:28939

object_name: schizoaffective disorder


subject: CHEBI:28939

object_name: schizophrenia 18


subject: UMLS:C1739076

object_name: Breast adenocarcinoma stage IV


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Stage IIIB Lung Cancer AJCC v7


subject: CHEBI:145371

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:145371

object_name: ALK Gene Rearrangement


subject: CHEBI:145371

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:145371

object_name: Stage IV Lung Cancer AJCC v6


subject: CHEBI:145371

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:145371

object_name: Progressive cGVHD


subject: CHEBI:145371

object_name: Progressive Disease


subject: CHEBI:145371

object_name: Progressive Neoplastic Disease


subject: CHEBI:145371

object_name: IMWG Progressive Disease


subject: CHEBI:145371

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:145371

object_name: Global Progressive Disease in Viscera


subject: CHEBI:145371

object_name: RECIL PD


subject: CHEBI:145371

object_name: Global Progressive Disease in Skin


subject: CHEBI:145371

object_name: Global Progressive Disease


subject: CHEBI:145371

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:145371

object_name: Global Progressive Disease in Blood


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: ROS1 gene rearrangement


subject: UNII:3DGD69C6PV

object_name: Stage IIIB Lung Cancer AJCC v7


subject: UNII:3DGD69C6PV

object_name: ALK Gene Rearrangement


subject: UNII:3DGD69C6PV

object_name: Stage IV Lung Cancer AJCC v7


subject: UNII:3DGD69C6PV

object_name: Stage IV Lung Cancer AJCC v6


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:92043599

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:92043599

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:92043599

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:92043599

object_name: chronic myelomonocytic leukemia


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Abnormal delivery


subject: CHEBI:94518

object_name: perinatal problems


subject: CHEBI:94518

object_name: cesarean section; complications


subject: UMLS:C5203174

subject_name: Epinephrine Liquid Injection

object_name: Allergy


subject: UMLS:C5203174

object_name: hypersensitivity reaction disease


subject: UMLS:C5203174

object_name: Allergic Reaction, CTCAE


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:3077

subject_name: Betamethasone

object_name: bronchiolitis


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Childhood Breast Carcinoma


subject: CHEBI:6375

object_name: breast carcinoma


subject: CHEBI:6375

object_name: breast cancer


subject: CHEBI:231683

subject_name: Anakinra

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: hormone-resistant prostate carcinoma


subject: UNII:2285XW22DR

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:2285XW22DR

object_name: Carcinoma of the prostate stage IV


subject: UNII:2285XW22DR

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:2285XW22DR

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:2285XW22DR

object_name: Prostate cancer recurrent


subject: UNII:2285XW22DR

object_name: prostate adenocarcinoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UMLS:C5445313

subject_name: Corn starch antigen

object_name: chronic kidney disease


subject: DRUGBANK:DB11599

subject_name: Starch, corn


subject: UNII:J81E81G364

subject_name: Efaproxiral


subject: UNII:J81E81G364


subject: UNII:J81E81G364


subject: UNII:J81E81G364

object_name: Embolism, Tumor


subject: UNII:J81E81G364

object_name: Neoplasm Metastasis


subject: UNII:J81E81G364

object_name: Metastatic Lesion


subject: PR:000034030

subject_name: FMN reductase (NADH) RutF

object_name: Acute malnutrition in childhood


subject: PR:000034030

object_name: Acute malnutrition in infancy


subject: PR:000034030

object_name: Underweight


subject: UMLS:C0003304

subject_name: Antifibrinolytic Agents

object_name: Cellulite


subject: UMLS:C3536773

subject_name: Antifibrinolytic Agent [EPC]


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: rhinoscleroma


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:2285XW22DR

object_name: HER2 positive breast carcinoma


subject: UNII:2285XW22DR

object_name: Stage IIIB Breast Carcinoma


subject: UNII:2285XW22DR

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: gingivitis


subject: PUBCHEM.COMPOUND:521372

object_name: periodontitis, chronic, adult


subject: GTOPDB:4881

object_name: periodontitis


subject: UNII:T472P45MG6

subject_name: Dibotermin alfa


subject: PR:000000164

subject_name: bone morphogenetic protein 2


subject: UMLS:C4087023

subject_name: Exviera

object_name: HCV coinfection


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:2735

object_name: obesity


subject: PUBCHEM.COMPOUND:2735

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Colon Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C5207033

subject_name: NanoPac

object_name: Locally Advanced Pancreatic Carcinoma


subject: UMLS:C5207033

object_name: prostate carcinoma


subject: UMLS:C5207033

object_name: prostate cancer


subject: UMLS:C5206814

subject_name: Submicron Particle Paclitaxel Sterile Suspension


subject: UMLS:C5206814


subject: UMLS:C5206814


subject: UMLS:C0005515

subject_name: Biological Factors

object_name: ulcerative colitis


subject: UMLS:C0005515

object_name: inflammatory bowel disease 1


subject: UMLS:C0005515

object_name: Crohn disease


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: Acne inversa


subject: CHEBI:8452

subject_name: Proflavine

object_name: squamous cell carcinoma


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: pancreatic neoplasm


subject: UMLS:C5847498

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5847498

object_name: malignant pancreatic neoplasm


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Metastatic non-small cell lung cancer


subject: GTOPDB:12990

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: GTOPDB:12990

object_name: Non-small cell lung cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: UNII:GKF8S4C432


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UMLS:C5207052


subject: UMLS:C5207052


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2269

object_name: eye infection


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: bacterial infectious disease


subject: CHEBI:63611


subject: CHEBI:74709

subject_name: Met-Trp

object_name: Severe Sepsis


subject: CHEBI:74709

object_name: septic shock


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Pancreatic cancer, adult


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Soft tissue rheumatism


subject: CHEBI:3160

object_name: myofascial pain syndrome


subject: CHEBI:3160

object_name: fibromyalgia


subject: CHEBI:3160

object_name: Headache


subject: CHEBI:3160

object_name: Pain Disorder


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: urothelial carcinoma


subject: CHEBI:41001

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Adult Meningioma


subject: CHEBI:38940

object_name: benign meningioma


subject: CHEBI:38940

object_name: familial meningioma


subject: CHEBI:38940

object_name: pediatric meningioma


subject: CHEBI:38940

object_name: meningioma


subject: CHEBI:38940

object_name: hemangioblastoma


subject: CHEBI:38940

object_name: Intracranial haemangiopericytoma


subject: CHEBI:38940

object_name: central nervous system cancer


subject: CHEBI:38940

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:38940

object_name: neurofibromatosis


subject: CHEBI:38940

object_name: neurofibromatosis 1


subject: CHEBI:38940

object_name: neurofibroma


subject: CHEBI:38940

object_name: neurofibromatosis type 1


subject: UNII:Q26B92650V

subject_name: Abequolixron

object_name: non-small cell lung carcinoma


subject: CHEBI:27470

subject_name: Folic acid

object_name: pneumonia


subject: CHEBI:27470

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:27470

object_name: diarrhea


subject: CHEBI:27470

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:27470

object_name: Diarrhea, CTCAE


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: trigger thumb


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Leptomeningeal Neoplasms


subject: CHEBI:231614

object_name: leptomeningeal melanoma


subject: CHEBI:231614

object_name: primary melanoma of the central nervous system


subject: CHEBI:231614

object_name: acral lentiginous melanoma


subject: CHEBI:231614

object_name: Metastatic Uveal Melanoma


subject: CHEBI:231614

object_name: Pigmented Nevus


subject: CHEBI:231614

object_name: Melanocytoma


subject: CHEBI:231614

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: breast neoplasm


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: mental disorder


subject: CHEBI:27300

object_name: psychiatric disorder


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: end stage renal failure


subject: CHEBI:68579

object_name: chronic kidney disease


subject: CHEBI:68579

object_name: Chronic uremia


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: adult glioblastoma


subject: UNII:15C2VL427D

object_name: Adult Gliosarcoma


subject: UNII:15C2VL427D

object_name: Adult Giant Cell Glioblastoma


subject: UNII:15C2VL427D

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:15C2VL427D

object_name: Adult Mixed Glioma


subject: UNII:15C2VL427D

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:15C2VL427D

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Pertrochanteric fracture


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:66903

subject_name: Vismodegib

object_name: myelofibrosis


subject: UMLS:C4546941

object_name: Chronic constipation


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: kidney disorder


subject: UNII:490D9F069T

object_name: impaired renal function disease


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:0M78EU4V9H


subject: MESH:C575838

object_name: inflammatory bowel disease


subject: MESH:C575838

object_name: irritable bowel syndrome


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:86319

subject_name: 25-hydroxyvitamin D2

object_name: HIV-1 infection


subject: CHEBI:86319

object_name: vitamin D deficiency


subject: CHEBI:86319

object_name: rickets


subject: CHEBI:17933

subject_name: Calcifediol


subject: CHEBI:17933


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: glycogen storage disease Ib


subject: CHEBI:44915

subject_name: Propofol

object_name: hypotension


subject: CHEBI:44915

object_name: Hypotension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: Richter syndrome


subject: UNII:30R67U9KYS


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: heart failure


subject: CHEBI:7986

object_name: congestive heart failure


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: focal epilepsy


subject: UMLS:C1259299

subject_name: Bronchipret


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: periodontitis


subject: CHEBI:36005

object_name: gingivitis


subject: CHEBI:36005

object_name: Inflammation


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:64356

subject_name: Pregabalin

object_name: chronic purulent otitis media


subject: PUBCHEM.COMPOUND:24936221

subject_name: Farxiga

object_name: type 2 diabetes mellitus


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: cannabis abuse


subject: PUBCHEM.COMPOUND:136033680

subject_name: Poly(ICLC)

object_name: Advanced Melanoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: PUBCHEM.COMPOUND:9794806

subject_name: HUPERZINE A

object_name: Alzheimer disease type 1


subject: CHEBI:178022

subject_name: huperzine A(1+)


subject: UMLS:C5706541

subject_name: Sirolimus Topical Gel PTX-022

object_name: microcystic lymphatic malformation


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEBI:31355

object_name: Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:31355

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: CHEBI:31355

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEBI:31355

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:31355

object_name: Refractory Grade 3b Follicular Lymphoma


subject: CHEBI:31355

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: CHEBI:31355

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:31355

object_name: Refractory Gray-Zone Lymphoma


subject: CHEBI:31355

object_name: Recurrent Gray-Zone Lymphoma


subject: CHEBI:31355

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:63791

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:63791

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692

object_name: Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:QQA9MLH692

object_name: Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:QQA9MLH692

object_name: Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:QQA9MLH692

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:QQA9MLH692

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:QQA9MLH692

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UNII:QQA9MLH692

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:QQA9MLH692

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UNII:QQA9MLH692

object_name: Refractory Gray-Zone Lymphoma


subject: UNII:QQA9MLH692

object_name: Recurrent Gray-Zone Lymphoma


subject: UNII:QQA9MLH692

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UMLS:C2987409


subject: UMLS:C2987409

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C2987409


subject: UMLS:C2987409

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C2987409

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C2987409

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C2987409

object_name: Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C2987409

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C2987409

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UMLS:C2987409

object_name: Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C2987409

object_name: Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C2987409

object_name: Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C2987409

object_name: Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type


subject: UMLS:C2987409

object_name: Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UMLS:C2987409

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C2987409

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C2987409

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UMLS:C2987409

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C2987409

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: UMLS:C2987409

object_name: Refractory Gray-Zone Lymphoma


subject: UMLS:C2987409

object_name: Recurrent Gray-Zone Lymphoma


subject: UMLS:C2987409

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: cardiovascular disorder


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: lung cancer


subject: CHEBI:63584

object_name: lung neoplasm


subject: CHEBI:63584

object_name: lung carcinoma


subject: CHEBI:51098

subject_name: Motesanib

object_name: neoplasm


subject: UMLS:C1541476

subject_name: AMG 706


subject: GTOPDB:9517

subject_name: atacicept

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: UMLS:C2351058

subject_name: Atacicept


subject: MESH:C403258

subject_name: si-wu-tang

object_name: brain ischemia


subject: UMLS:C0911601


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: Epigenetic disorder


subject: UNII:DEW6X41BEK

object_name: Dermatitis


subject: PUBCHEM.COMPOUND:25215428

subject_name: ainuovirine

object_name: AIDS


subject: UMLS:C3252041

object_name: pulmonary tuberculosis


subject: UMLS:C3467978


subject: UNII:31D90UKP5Y

subject_name: hydroxyflutamide

object_name: prostate carcinoma


subject: UNII:31D90UKP5Y

object_name: prostate cancer


subject: UMLS:C4049116


subject: UMLS:C4049116


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Acute Pain


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: brain injury


subject: UMLS:C5814322

subject_name: Porphobilinogen deaminase, human recombinant

object_name: acute intermittent porphyria


subject: UMLS:C5814323

subject_name: Porphozym


subject: CHEBI:75283

subject_name: Miltefosine

object_name: Chiclero ulcer


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: Immunization reaction


subject: PR:000022848

subject_name: guanosine-inosine kinase


subject: PR:000022848


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: UniProtKB:P0AEW6


subject: UMLS:C1564420

subject_name: Tolperisone Hydrochloride

object_name: Spasticity


subject: CHEBI:93835

subject_name: Tolperisone


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: generalized vitiligo


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Cirrhosis


subject: CHEBI:4670

object_name: liver cirrhosis


subject: CHEBI:4670

object_name: cirrhotic cardiomyopathy


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Alzheimer disease type 1


subject: UNII:QP49AY37OY

object_name: post-traumatic stress disorder


subject: DRUGBANK:DB19048


subject: MESH:D056692

subject_name: Prebiotics

object_name: type 2 diabetes mellitus


subject: UNII:I4965C6W4O

object_name: cancer


subject: UNII:I4965C6W4O

object_name: neoplasm


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation

object_name: Vomiting, CTCAE


subject: UMLS:C1161331

object_name: Vomiting


subject: UMLS:C1161331

object_name: Acute gastroenteritis


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:17992


subject: CHEBI:76978

subject_name: Tricaprylin

object_name: developmental and epileptic encephalopathy


subject: CHEBI:76978

object_name: West syndrome


subject: CHEBI:76978

object_name: Infantile Spasm


subject: UMLS:C2830036


subject: UMLS:C2830036

object_name: Tumor Mass


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:521372

object_name: schizophrenia 18


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: metastatic colorectal cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: primary central nervous system lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:74947

subject_name: Thalidomide

object_name: yolk sac tumor


subject: CHEBI:74947

object_name: adult yolk sac tumor


subject: CHEBI:74947

object_name: testicular yolk sac tumor


subject: CHEBI:74947

object_name: ovarian yolk sac tumor


subject: CHEBI:74947

object_name: vaginal yolk sac tumor


subject: CHEBI:74947

object_name: adult germ cell tumor


subject: CHEBI:74947

object_name: germ cell tumor


subject: CHEBI:74947

object_name: childhood germ cell tumor


subject: CHEBI:74947

object_name: Germ Cell Cancer


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:231614

subject_name: Nivolumab

object_name: sarcomatoid renal cell carcinoma


subject: UMLS:C2346820


subject: CHEBI:16899

subject_name: Mannitol

object_name: acute liver failure


subject: PUBCHEM.COMPOUND:152165

object_name: common bile duct disorder


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: cardiovascular disorder


subject: CHEBI:71196

object_name: arteriosclerosis disorder


subject: CHEBI:71196

object_name: atherosclerosis


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors


subject: MESH:D000077203


subject: MESH:D000077203


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UMLS:C3542461


subject: PUBCHEM.COMPOUND:9831939

subject_name: Xalacom

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:9831939

object_name: Ocular hypertension


subject: PUBCHEM.COMPOUND:9831939

object_name: glaucoma


subject: PUBCHEM.COMPOUND:9831939

object_name: Glaucoma, CTCAE


subject: MESH:C571753


subject: MESH:C571753


subject: MESH:C571753


subject: MESH:C571753


subject: CHEBI:95165

object_name: castration-resistant prostate carcinoma


subject: CHEBI:95165

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:95165

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Diabetes


subject: CHEBI:3286

object_name: diabetes mellitus


subject: UNII:6ZQ8Q3CB8R

object_name: herpes simplex


subject: CHEBI:75551


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Alzheimer disease type 1


subject: UMLS:C0013227

object_name: brain disorder


subject: UMLS:C0013227

object_name: cognitive disorder


subject: UMLS:C0013227

object_name: nervous system disorder


subject: UMLS:C0013227

object_name: CNS disorder


subject: UMLS:C0013227

object_name: mental disorder


subject: UMLS:C0013227

object_name: psychiatric disorder


subject: UMLS:C0013227

object_name: tauopathy


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:79033

subject_name: florbetaben F18


subject: CHEBI:79033


subject: CHEBI:79033

object_name: neurodegenerative disease


subject: CHEBI:79033


subject: CHEBI:79033


subject: CHEBI:79033


subject: CHEBI:79033


subject: CHEBI:79033


subject: CHEBI:79033

object_name: Presenile dementia


subject: CHEBI:79033

object_name: dementia


subject: PUBCHEM.COMPOUND:6320532

subject_name: Cenicriviroc


subject: PUBCHEM.COMPOUND:6320532

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:6320532

object_name: liver cirrhosis


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4086713

object_name: acute myeloid leukemia


subject: CHEBI:232799

subject_name: insulin lispro

object_name: Lipohypertrophy


subject: CHEBI:232799

object_name: Lipohypertrophy, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:90881

subject_name: Camptosar

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: mild neurocognitive disorder


subject: UNII:T42P99266K

object_name: mild cognitive impairment


subject: UNII:T42P99266K

object_name: Alzheimer disease


subject: UNII:T42P99266K

object_name: Alzheimer disease type 1


subject: UNII:T42P99266K

object_name: Alzheimer disease 3


subject: UNII:T42P99266K

object_name: Admitting diagnosis


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: type 1 diabetes mellitus 1


subject: CHEBI:4356

object_name: type 1 diabetes mellitus


subject: CHEBI:187893

subject_name: Baclofen

object_name: cannabis abuse


subject: PUBCHEM.COMPOUND:135718449

object_name: Crohn disease


subject: UNII:1W5N8SZD9A

subject_name: Glufosfamide

object_name: pancreatic neoplasm


subject: UNII:1W5N8SZD9A

object_name: exocrine pancreatic carcinoma


subject: UNII:1W5N8SZD9A

object_name: malignant pancreatic neoplasm


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Stomach cancer


subject: CHEBI:25681

object_name: gastric cancer


subject: UMLS:C3541937

subject_name: Azadirachta indica whole extract

object_name: periodontitis


subject: CHEBI:45783

subject_name: Imatinib

object_name: asthma


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: Malignant melanoma of skin of breast


subject: DRUGBANK:DB17468

object_name: breast cancer


subject: UMLS:C2698691

subject_name: Imprime PGG


subject: UMLS:C2698691


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: ST-elevation myocardial infarction


subject: CHEBI:31348

subject_name: Capecitabine

object_name: pancreas disorder


subject: CHEBI:31348

object_name: malignant endocrine neoplasm


subject: CHEBI:31348

object_name: endocrine gland neoplasm


subject: CHEBI:31348

object_name: endocrine system disorder


subject: CHEBI:31348

object_name: glandular cell neoplasm


subject: CHEBI:31348

object_name: lung adenocarcinoma


subject: CHEBI:31348

object_name: cervical adenocarcinoma


subject: CHEBI:31348

object_name: adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:2767

object_name: digestive system disorder


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: bile duct adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: gastric adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: MESH:C000721991


subject: CHEBI:50858

subject_name: corticosteroid

object_name: inflammatory bowel disease 1


subject: CHEBI:50858

object_name: Crohn disease


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UNII:S98NFM1378

object_name: lymphoma


subject: UMLS:C4053636

subject_name: EGFR Antagonist Hemay022

object_name: Childhood Breast Carcinoma


subject: UMLS:C4053636

object_name: breast carcinoma


subject: UMLS:C4053636

object_name: breast cancer


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: diabetic kidney disease


subject: CHEBI:32016

object_name: type 2 diabetes mellitus


subject: CHEBI:60802

subject_name: ropivacaine

object_name: head and neck neoplasm


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Multiple actinic keratoses


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:50749

subject_name: Calcipotriol


subject: CHEBI:231683

subject_name: Anakinra

object_name: adult-onset Still disease


subject: CHEBI:231683

object_name: Still Disease


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:8382

subject_name: Prednisone

object_name: interstitial lung disease


subject: GTOPDB:8313

subject_name: talazoparib

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:8313

object_name: small cell lung carcinoma


subject: GTOPDB:8313

object_name: pancreatic neoplasm


subject: GTOPDB:8313

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:8313

object_name: malignant pancreatic neoplasm


subject: GTOPDB:8313

object_name: Ewing sarcoma


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Erosive esophagitis


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:91397

object_name: acute lymphoblastic leukemia


subject: CHEBI:91397

object_name: acute biphenotypic leukemia


subject: CHEBI:91397

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:91397

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: leukemia


subject: CHEBI:31587

object_name: childhood leukemia


subject: CHEBI:31587

object_name: Myelodysplasia


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: congenital alveolar dysplasia


subject: CHEBI:41879

object_name: newborn respiratory distress syndrome


subject: CHEBI:7660

subject_name: nystatin

object_name: systemic mycosis


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: melanoma


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Recurrent ovarian cancer


subject: CHEBI:22198

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:22198

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:22198

object_name: ovarian endometrial cancer


subject: CHEBI:22198

object_name: ovarian serous adenocarcinoma


subject: CHEBI:22198

object_name: malignant ovarian serous tumor


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UMLS:C0338133

subject_name: Gemzar

object_name: cervical cancer


subject: UMLS:C0338133

object_name: cervical carcinoma


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: Non-small cell lung cancer stage III


subject: CHEBI:6504

object_name: thyroid tumor


subject: CHEBI:6504

object_name: thyroid gland carcinoma


subject: CHEBI:6504

object_name: thyroid cancer


subject: CHEBI:6504

object_name: differentiated thyroid carcinoma


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents

object_name: Hypoxemia


subject: UMLS:C0042397

object_name: Hypoxia, CTCAE


subject: CHEBI:177533

subject_name: Quarfloxin

object_name: adult lymphoma


subject: CHEBI:177533

object_name: lymphoma


subject: CHEBI:177533

object_name: pediatric lymphoma


subject: MESH:C545184


subject: MESH:C545184


subject: MESH:C545184


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Post transplant diabetes mellitus


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: RAS Wild Type


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0591039

subject_name: Adcortyl

object_name: lichen planus, oral


subject: PUBCHEM.COMPOUND:3027380

object_name: cataract


subject: PUBCHEM.COMPOUND:3027380

object_name: Cataract, CTCAE 3.0


subject: PUBCHEM.COMPOUND:3027380

object_name: Cataract, CTCAE 5.0


subject: PUBCHEM.COMPOUND:3027380

object_name: cataract on exam (physical finding)


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Inflammation


subject: CHEBI:74705

object_name: neuralgia


subject: CHEBI:74705

object_name: Neuralgia, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: MESH:D000941

subject_name: Antigens

object_name: non-small cell lung carcinoma


subject: UMLS:C5962495

subject_name: Anti-NaPi2b/Exatecan Antibody-drug Conjugate TUB-040

object_name: ovarian cancer


subject: UMLS:C5962495

object_name: ovarian neoplasm


subject: UMLS:C5962495

object_name: ovarian carcinoma


subject: UMLS:C5962495


subject: UMLS:C1999530

object_name: Gaucher disease type I


subject: CHEBI:83353

subject_name: Agalsidase beta


subject: CHEBI:7772

subject_name: omeprazole

object_name: Cough


subject: CHEBI:7772

object_name: Cough, CTCAE


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: cardiac sarcoidosis


subject: UMLS:C2343505

subject_name: Arcalyst


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: multiple system atrophy


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: rectal carcinoma


subject: UNII:DPT0O3T46P

object_name: rectal cancer


subject: UNII:DPT0O3T46P

object_name: Childhood Rectal Carcinoma


subject: UNII:DPT0O3T46P

object_name: rectal neoplasm


subject: CHEBI:60799

subject_name: Esketamine

object_name: inflammatory bowel disease 1


subject: CHEBI:60799

object_name: Crohn disease


subject: CHEBI:8772

subject_name: Raloxifene

object_name: Depressive Syndrome


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: EXCESS LMW-DNA


subject: UNII:74T7185BMM

subject_name: Inebilizumab


subject: UMLS:C2981806


subject: CHEBI:64312

subject_name: Memantine

object_name: Chronic schizophrenia


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: OPTN-related open angle glaucoma


subject: CHEBI:194095

object_name: open-angle glaucoma


subject: CHEBI:194095

object_name: glaucoma


subject: CHEBI:194095

object_name: Glaucoma, CTCAE


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: peritoneal neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: fallopian tube neoplasm


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:91368

object_name: plasma cell myeloma


subject: UNII:2JJ274J145

subject_name: Aspisol

object_name: aspirin resistance


subject: UNII:XAN4V337CI

subject_name: Aspirin lysine


subject: CHEBI:91697

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91697

object_name: leukemia


subject: CHEBI:91697

object_name: childhood leukemia


subject: CHEBI:65310

subject_name: Triciribine


subject: CHEBI:65310


subject: CHEBI:65310


subject: UNII:2S9ZZM9Q9V

object_name: Ovarian clear cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian clear cell cancer


subject: UMLS:C5206815


subject: UMLS:C5206815


subject: CHEBI:50634

object_name: cystoid macular edema


subject: CHEBI:27690

subject_name: Acetazolamide


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection


subject: UNII:2456KW2166

object_name: hepatitis B


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: alcohol abuse


subject: CHEBI:30830

object_name: alcohol dependence


subject: UNII:QX6O64GP40

subject_name: Proxalutamide

object_name: Carcinoma breast stage IV


subject: GTOPDB:13624

subject_name: inclisiran

object_name: hyperlipidemia


subject: GTOPDB:13624

object_name: hyperlipoproteinemia


subject: GTOPDB:13624

object_name: Hyperlipidemia, CTCAE


subject: GTOPDB:13624

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: fibromyalgia


subject: CHEBI:125628

subject_name: Alisertib

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:125628

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: idiopathic scoliosis


subject: CHEBI:3160

object_name: adolescent idiopathic scoliosis


subject: CHEBI:3160

object_name: Lumbar scoliosis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:73151030

object_name: Methotrexate adverse reaction


subject: UMLS:C1328153

subject_name: ILX 651

object_name: melanoma


subject: UNII:01KC87F8FE

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:42941

object_name: intrahepatic cholangiocarcinoma


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: pustular psoriasis


subject: CHEBI:24433

subject_name: group

object_name: stroke disorder


subject: CHEBI:24433

object_name: cerebrovascular disorder


subject: CHEBI:24433

object_name: Stroke (heart beat)


subject: CHEBI:24433

object_name: Stroke, CTCAE


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:23965


subject: PR:000007559

object_name: chronic kidney disease


subject: UMLS:C2917382

subject_name: Erythropoiesis-stimulating Agent [EPC]


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Reactive hypoglycemia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: stage IV pancreatic cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pancreatic carcinoma stage III


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: recurrent islet cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UNII:2S9ZZM9Q9V

object_name: pancreatic somatostatinoma


subject: UNII:2S9ZZM9Q9V

object_name: somatostatinoma


subject: UNII:2S9ZZM9Q9V

object_name: glucagonoma


subject: UNII:2S9ZZM9Q9V

object_name: insulinoma


subject: UNII:2S9ZZM9Q9V

object_name: Zollinger-Ellison syndrome


subject: UNII:2S9ZZM9Q9V

object_name: gastrinoma


subject: UNII:2S9ZZM9Q9V

object_name: pancreatic gastrinoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: PPoma


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0919079

object_name: stage IV pancreatic cancer


subject: UMLS:C0919079

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C0919079

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C0919079

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C0919079

object_name: Pancreatic carcinoma stage III


subject: UMLS:C0919079

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: recurrent islet cell carcinoma


subject: UMLS:C0919079

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UMLS:C0919079

object_name: pancreatic somatostatinoma


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Small cell lung cancer limited stage


subject: UMLS:C3641122


subject: UMLS:C0873019

subject_name: Berberine hydrochloride

object_name: Prediabetes


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: Prevention problem


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:49956

subject_name: Xenon

object_name: scleroderma


subject: CHEBI:49956

object_name: systemic sclerosis


subject: CHEBI:94534

subject_name: olanzapine

object_name: delirium


subject: CHEBI:94534

object_name: Delirium, CTCAE


subject: CHEBI:94534

object_name: Agitation, CTCAE 3.0


subject: CHEBI:94534

object_name: Agitation


subject: CHEBI:94534

object_name: Agitation, CTCAE 5.0


subject: CHEBI:29191

subject_name: hydroxyl

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:29191

object_name: Deficiency of vitamin D3


subject: CHEBI:29191

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: UMLS:C0700307


subject: UMLS:C0700307


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:16234


subject: CHEBI:16234


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C5706551

subject_name: Anti-CEACAM5 Antibody-drug Conjugate M9140

object_name: colorectal cancer


subject: UMLS:C5706551

object_name: colorectal carcinoma


subject: UMLS:C5706551

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:71013

subject_name: Perampanel

object_name: Refractory status epilepticus


subject: GTOPDB:9110

object_name: tenosynovial giant cell tumor


subject: GTOPDB:9110

object_name: tenosynovial giant cell tumor, diffuse type


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: CHEBI:73896

subject_name: Gly-D-Thr

object_name: Post-Operative Pain


subject: CHEBI:73920

subject_name: Gly-Thr


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: adult lymphoma


subject: CHEBI:191174

object_name: lymphoma


subject: CHEBI:191174

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:30006

subject_name: L-leucine residue

object_name: Muscle Atrophy


subject: CHEBI:33372

subject_name: Neodymium


subject: CHEBI:73419

subject_name: Asn-Asp


subject: UMLS:C2703118

object_name: plasma cell myeloma


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Localized Resectable Neuroblastoma


subject: UNII:M89N0Q7EQR

object_name: Localized Unresectable Neuroblastoma


subject: PR:000001379


subject: PR:000001379


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab


subject: UNII:7SQY4ZUD30


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: diabetic hyperglycaemia


subject: UMLS:C1099192


subject: UMLS:C1950497

subject_name: optive

object_name: macular degeneration


subject: UMLS:C1950497

object_name: age-related macular degeneration


subject: UMLS:C1950497

object_name: retinitis pigmentosa 30


subject: UMLS:C1950497

object_name: retinal artery occlusion


subject: UMLS:C1950497

object_name: degenerative myopia


subject: UMLS:C1950497

object_name: diabetic retinopathy


subject: CHEBI:87715

subject_name: Prasugrel

object_name: heart disorder


subject: UMLS:C0914294


subject: UMLS:C0914294

object_name: cardiovascular disorder


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: lung cancer


subject: UNII:6A901E312A

object_name: lung neoplasm


subject: UNII:6A901E312A

object_name: lung carcinoma


subject: UMLS:C5447522

subject_name: Myeloid Cell Leukemia 1 Inhibitor PRT1419

object_name: cervical cancer


subject: UMLS:C5447522

object_name: cervical carcinoma


subject: UMLS:C5447522

object_name: Neck Carcinoma


subject: UMLS:C5447522

object_name: head and neck neoplasm


subject: UMLS:C5447522

object_name: head and neck cancer


subject: UMLS:C5447522

object_name: carcinoma of esophagus


subject: UMLS:C5447522

object_name: esophageal cancer


subject: UMLS:C5447522

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5447522

object_name: neoplasm of esophagus


subject: UMLS:C5447522

object_name: Childhood Breast Carcinoma


subject: UMLS:C5447522

object_name: breast carcinoma


subject: UMLS:C5447522

object_name: breast cancer


subject: UMLS:C5447522


subject: UMLS:C5447522


subject: UMLS:C5447522


subject: UMLS:C5447522

object_name: melanoma


subject: UMLS:C5447522

object_name: malignant soft tissue neoplasm


subject: UMLS:C5447522

object_name: sarcoma


subject: CHEMBL.COMPOUND:CHEMBL3707352

subject_name: policosanol

object_name: Hypercholesterolemia


subject: CHEBI:4659

subject_name: Disulfiram

object_name: Hereditary retinal dystrophy primarily involving sensory retina


subject: UMLS:C1631115

subject_name: Mucinex D

object_name: Acute respiratory infections


subject: UMLS:C1631115

object_name: Rhinosinusitis


subject: UMLS:C1631115

object_name: bronchitis


subject: UMLS:C1631115

object_name: Acute bronchitis


subject: CHEBI:5551

subject_name: Guaifenesin


subject: CHEBI:5551


subject: CHEBI:5551


subject: CHEBI:5551


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Hodgkin Disease


subject: CHEBI:74705

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:74705

object_name: Childhood Hodgkin Lymphoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:7772

subject_name: omeprazole

object_name: chronic laryngitis


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:15365

subject_name: Aspirin

object_name: liver carcinoma


subject: UNII:UCG949AA7Z

subject_name: ADAGLOXAD SIMOLENIN

object_name: triple-negative breast carcinoma


subject: UNII:UCG949AA7Z

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:11546

subject_name: aldafermin

object_name: kidney failure


subject: CHEMBL.COMPOUND:CHEMBL4298055

subject_name: ALDAFERMIN


subject: UMLS:C5418311


subject: UMLS:C5435429


subject: UMLS:C1327951

object_name: adult lymphoma


subject: UMLS:C1327951

object_name: lymphoma


subject: UMLS:C1327951

object_name: pediatric lymphoma


subject: UMLS:C1327951

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C1327951

object_name: non-small cell lung carcinoma


subject: GTOPDB:13826

subject_name: pegcetacoplan


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: CHEBI:29321

subject_name: sodium nitroprusside

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:29321

object_name: Acute heart failure


subject: UNII:EAO03PE1TC

subject_name: Sodium nitroprusside hydrate


subject: UNII:EAO03PE1TC


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: obstructive sleep apnea syndrome


subject: UNII:DI4N99Q6KK

subject_name: PERESOLIMAB

object_name: rheumatoid arthritis


subject: UNII:DI4N99Q6KK

object_name: arthritis


subject: UNII:DI4N99Q6KK

object_name: Arthritis, CTCAE


subject: UNII:DI4N99Q6KK

object_name: Rheumatism


subject: UNII:DI4N99Q6KK

object_name: connective tissue disorder


subject: UNII:DI4N99Q6KK

object_name: musculoskeletal system disorder


subject: UNII:DI4N99Q6KK

object_name: immune system disorder


subject: UNII:DI4N99Q6KK

object_name: Autoimmunity


subject: UNII:DI4N99Q6KK

object_name: arthropathy


subject: UMLS:C5670508

subject_name: Peresolimab


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: UMLS:C5670508


subject: CHEBI:36791

subject_name: Escitalopram

object_name: poikiloderma with neutropenia


subject: CHEBI:36791

object_name: prurigo nodularis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:31547

subject_name: Eplerenone

object_name: end stage renal failure


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:5790

object_name: Back pain


subject: CHEBI:5790

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:60799

subject_name: Esketamine

object_name: Suicidal ideation


subject: CHEBI:60799

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:60799

object_name: mood disorder


subject: UNII:H9E1T0BI90

subject_name: DESVENLAFAXINE SUCCINATE

object_name: Vascular Depression


subject: CHEBI:83527

subject_name: Desvenlafaxine


subject: UMLS:C2348261

subject_name: Dietary Chromium

object_name: Androgen excess


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: colorectal cancer


subject: CHEBI:53498

object_name: colorectal carcinoma


subject: CHEBI:53498

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2962221

subject_name: TAC


subject: UMLS:C2962221


subject: UMLS:C2962221


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: spinal cord injury


subject: UNII:6XC1PAD3KF

object_name: acute spinal cord injury


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:93235

subject_name: flupentixol

object_name: Globus Hystericus


subject: CHEBI:5121

subject_name: flupenthixol


subject: CHEBI:135214

subject_name: Melitracen


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:144903

object_name: vitiligo


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: CHEBI:51098

subject_name: Motesanib

object_name: pancreatic neuroendocrine neoplasm


subject: CHEBI:51098

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:51098

object_name: Gastrointestinal Carcinoid Tumor


subject: CHEBI:51098

object_name: neoplastic syndrome


subject: UMLS:C1541476

subject_name: AMG 706


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: UMLS:C1541476


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:7726


subject: DRUGBANK:DB06432

object_name: hemolytic-uremic syndrome


subject: DRUGBANK:DB06432

object_name: Hemolytic Uremic Syndrome, CTCAE


subject: MESH:C119238

subject_name: SYNSORB Pk


subject: MESH:C119238


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Angina pectoris


subject: CHEBI:84040

object_name: Wheezing


subject: CHEBI:84040

object_name: Wheezing, CTCAE


subject: CHEBI:84040

object_name: Upper Respiratory Infections


subject: CHEBI:84040

object_name: respiratory tract infectious disorder


subject: CHEBI:84040

object_name: Recurrent upper respiratory tract infections


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Non-small cell lung cancer recurrent


subject: UNII:PQX0D8J21J

object_name: Plexosarcoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UNII:PQX0D8J21J

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UNII:PQX0D8J21J

object_name: metastatic gastrointestinal carcinoid tumor


subject: UNII:PQX0D8J21J

object_name: Anal cancer recurrent


subject: UNII:PQX0D8J21J

object_name: Anal cancer stage IV


subject: UNII:PQX0D8J21J

object_name: Stage IV Anal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Small intestine carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: small intestine lymphoma


subject: UNII:PQX0D8J21J

object_name: recurrent gastric cancer


subject: UNII:PQX0D8J21J

object_name: advanced adult primary liver cancer


subject: UNII:PQX0D8J21J

object_name: Oesophageal carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Salivary gland cancer stage IV


subject: UNII:PQX0D8J21J

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: appendix carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UNII:PQX0D8J21J

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: stage IV esophageal cancer


subject: UNII:PQX0D8J21J

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:PQX0D8J21J

object_name: small intestine leiomyosarcoma


subject: UNII:PQX0D8J21J

object_name: small intestine adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: Pancreatic carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Recurrent Cancer of Gallbladder


subject: UNII:PQX0D8J21J

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:PQX0D8J21J

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: stage IV pancreatic cancer


subject: UNII:PQX0D8J21J

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:PQX0D8J21J

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C0879636

object_name: Plexosarcoma


subject: UMLS:C0879636

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: UMLS:C0879636

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C0879636

object_name: metastatic gastrointestinal carcinoid tumor


subject: UMLS:C0879636

object_name: Anal cancer recurrent


subject: UMLS:C0879636

object_name: Anal cancer stage IV


subject: UMLS:C0879636

object_name: Stage IV Anal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: Small intestine carcinoma recurrent


subject: UMLS:C0879636

object_name: small intestine lymphoma


subject: UMLS:C0879636

object_name: recurrent gastric cancer


subject: UMLS:C0879636

object_name: advanced adult primary liver cancer


subject: UMLS:C0879636

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C0879636

object_name: Salivary gland cancer stage IV


subject: UMLS:C0879636

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C0879636

object_name: appendix carcinoma


subject: UMLS:C0879636

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UMLS:C0879636

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UMLS:C0879636

object_name: stage IV esophageal cancer


subject: UMLS:C0879636

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C0879636

object_name: small intestine leiomyosarcoma


subject: UMLS:C0879636

object_name: small intestine adenocarcinoma


subject: UMLS:C0879636

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C0879636

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C0879636

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C0879636

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UMLS:C0879636

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C0879636

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: stage IV pancreatic cancer


subject: UMLS:C0879636

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C0879636

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UMLS:C0879636

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Plexosarcoma


subject: CHEBI:114785

object_name: Recurrent Digestive System Neuroendocrine Tumor G1


subject: CHEBI:114785

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:114785

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEBI:114785

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:114785

object_name: Small intestine carcinoma recurrent


subject: CHEBI:114785

object_name: small intestine lymphoma


subject: CHEBI:114785

object_name: recurrent gastric cancer


subject: CHEBI:114785

object_name: colon adenocarcinoma


subject: CHEBI:114785

object_name: appendix carcinoma


subject: CHEBI:114785

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:114785

object_name: small intestine leiomyosarcoma


subject: CHEBI:114785

object_name: small intestine adenocarcinoma


subject: CHEBI:114785

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:114785

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:114785

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:114785

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:114785

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:2663

subject_name: Amiodarone

object_name: stroke disorder


subject: CHEBI:2663

object_name: cerebrovascular disorder


subject: CHEBI:2663

object_name: Sudden death


subject: CHEBI:63622

subject_name: Sotalol

object_name: atrial fibrillation


subject: CHEBI:63622

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:63622

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:63622


subject: CHEBI:63622


subject: CHEBI:63622


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: central nervous system germ cell tumor


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:82663

subject_name: elemental iron

object_name: anemia


subject: CHEBI:82663

object_name: Anemia, CTCAE


subject: UMLS:C1602113

subject_name: OxyNorm

object_name: Acute Pain


subject: UMLS:C1576821

subject_name: micafungin sodium

object_name: hematologic disorder


subject: UMLS:C1576821

object_name: Febrile Neutropenia


subject: UMLS:C1576821

object_name: Febrile Neutropenia, CTCAE


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin


subject: PUBCHEM.COMPOUND:78357831


subject: PUBCHEM.COMPOUND:78357831


subject: PUBCHEM.COMPOUND:132212657

subject_name: Revumenib

object_name: acute leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: Childhood Acute Leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:132212657

object_name: Childhood Acute Leukemia of Ambiguous Lineage


subject: PUBCHEM.COMPOUND:132212657

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:169490859

subject_name: Revumenib citrate


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:23725028

subject_name: Stanate (TN)

object_name: Nutritional and Metabolic Diseases


subject: CHEMBL.COMPOUND:CHEMBL4297207

subject_name: STANNSOPORFIN


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: Acute retention of urine


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: colon adenocarcinoma


subject: MESH:C000730795

object_name: Sedation


subject: MESH:C000730795

object_name: Sedated


subject: MESH:C000730795

object_name: hypotension


subject: UMLS:C1328149

object_name: liver failure


subject: CHEBI:66910

subject_name: Axitinib


subject: UMLS:C4305866

object_name: Laron syndrome


subject: UMLS:C4305866

object_name: Growth hormone insensitivity syndrome (GHIS)


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: asthma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: metastatic melanoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: Advanced cancer


subject: UNII:8L7891MRB6

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:V0Q46LFE6F


subject: UNII:V0Q46LFE6F


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931

object_name: colorectal cancer


subject: CHEBI:6931

object_name: colorectal carcinoma


subject: CHEBI:6931

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: UNII:2158753C7E

subject_name: Relacorilant

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:75551


subject: CHEBI:52763


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: leukemia


subject: CHEBI:17061

object_name: childhood leukemia


subject: CHEBI:17061

object_name: renal carcinoma


subject: CHEBI:17061

object_name: kidney neoplasm


subject: CHEBI:17061

object_name: kidney cancer


subject: CHEBI:17061

object_name: peripheral nervous system disorder


subject: CHEBI:17061

object_name: neuropathy


subject: CHEBI:17061

object_name: neurotoxicity


subject: CHEBI:17061

object_name: malignant soft tissue neoplasm


subject: CHEBI:17061

object_name: sarcoma


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:5466794

object_name: prostate cancer


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:90205

subject_name: Plitidepsin

object_name: Relapsed/refractory multiple myeloma


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: UMLS:C0388638

subject_name: plitidepsin


subject: CHEBI:7421

subject_name: NAC

object_name: Compulsion


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: chronic kidney disease


subject: UNII:7UQ7X4Y489

object_name: Chronic uremia


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: CHEBI:151315

subject_name: Heparin

object_name: Pregnant


subject: CHEBI:151315

object_name: cesarean section; complications


subject: CHEBI:151315

object_name: Deep venous thrombosis in puerperium


subject: CHEBI:151315

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:151315

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:151315

object_name: morbid obesity


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:E47C0NF7LV

object_name: obesity


subject: UNII:E47C0NF7LV

object_name: Obesity, CTCAE


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:TUK9QB44B0

object_name: psoriatic arthritis


subject: UMLS:C5392518


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Androgen excess


subject: CHEBI:7726

subject_name: octreotide

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate

object_name: staphylococcus aureus infection


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:90687

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1831929


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Childhood Breast Carcinoma


subject: CHEBI:6950

object_name: breast carcinoma


subject: CHEBI:6950

object_name: breast cancer


subject: CHEBI:2659

subject_name: Aminophylline

object_name: cardiac arrest


subject: CHEBI:2659

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Stress


subject: CHEBI:134709

subject_name: Pitolisant

object_name: Restless legs


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: Childhood Diffuse Large Cell Lymphoma


subject: MESH:C508870

object_name: Adult Diffuse Large Cell Lymphoma


subject: UNII:DRP53ZDY6H

object_name: pancreatic neoplasm


subject: UNII:DRP53ZDY6H

object_name: exocrine pancreatic carcinoma


subject: UNII:DRP53ZDY6H

object_name: malignant pancreatic neoplasm


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: sexually transmitted disease


subject: UMLS:C0037668

object_name: HIV-1 infection


subject: UMLS:C4287789

object_name: celiac disease


subject: UMLS:C1171407

subject_name: Gliadel Wafer

object_name: glioblastoma


subject: UMLS:C1171407

object_name: Childhood Glioblastoma


subject: UMLS:C1171407

object_name: adult glioblastoma


subject: CHEBI:9605

subject_name: Tirofiban

object_name: acute coronary syndrome


subject: UMLS:C1137157

object_name: human African trypanosomiasis


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: Refractory Neuroblastoma


subject: UNII:7SQY4ZUD30

object_name: Osteosarcoma recurrent


subject: UNII:7SQY4ZUD30

object_name: Refractory Osteosarcoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0392938

subject_name: zoledronate


subject: UMLS:C0392938

object_name: Childhood Neuroblastoma


subject: UMLS:C0392938

object_name: neuroblastoma


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UMLS:C0392938

object_name: Neuroblastoma recurrent


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: UMLS:C3714249

object_name: cholestasis


subject: UMLS:C2987634

subject_name: Agonist

object_name: infertility


subject: CHEBI:50730

subject_name: Montelukast

object_name: perennial allergic rhinitis


subject: CHEBI:94559

subject_name: Levocetirizine


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: PUBCHEM.COMPOUND:3367

object_name: complications of organ transplant stem cells


subject: PUBCHEM.COMPOUND:3367

object_name: Engraft failure


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage I Oropharyngeal Carcinoma


subject: UMLS:C3827082


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Premature infant


subject: CHEBI:585948

subject_name: Felodipine

object_name: hypertension


subject: CHEBI:585948

object_name: Hypertension, CTCAE


subject: CHEBI:23965

subject_name: estradiol

object_name: ovarian disease


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Colorectal cancer stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:44424639

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:44424639

object_name: anaplastic large cell lymphoma


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:7466

subject_name: Nandrolone

object_name: Malignant cachexia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:2S9ZZM9Q9V

object_name: salivary gland squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: tongue cancer


subject: UNII:2S9ZZM9Q9V

object_name: tongue carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Salivary Gland Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Oral Cavity Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Oral Cavity Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Oral Cavity Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1831889

object_name: postmenopausal osteoporosis


subject: UNII:52CMI0WC3Y

object_name: Metastatic Clear Cell Sarcoma of Soft Tissue


subject: UNII:52CMI0WC3Y

object_name: dedifferentiated chondrosarcoma


subject: UNII:52CMI0WC3Y

object_name: Central Chondrosarcoma, Grade 3


subject: UNII:52CMI0WC3Y

object_name: Central Chondrosarcoma, Grade 2


subject: UNII:52CMI0WC3Y

object_name: Unresectable Primary Central Chondrosarcoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Primary Central Chondrosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:78432

subject_name: Ceritinib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:75179

subject_name: Trifluridine

object_name: GASTRIC CANCER ADENOCARCINOMA METASTATIC


subject: CHEBI:90879

subject_name: Tipiracil


subject: DRUGBANK:DB08937


subject: CHEBI:90876

subject_name: Lonsurf


subject: UNII:2S9ZZM9Q9V


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: osteoarthritis, knee


subject: UMLS:C2718754

subject_name: Ilaris

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:166177189

subject_name: Nerandomilast

object_name: interstitial lung disease 1


subject: PUBCHEM.COMPOUND:166177189

object_name: interstitial lung disease 2


subject: UNII:I5DGT51IB8

subject_name: NERANDOMILAST


subject: UNII:I5DGT51IB8


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: autoimmune thrombocytopenia


subject: UNII:73B0K5S26A

object_name: thrombocytopenia due to immune destruction


subject: UNII:73B0K5S26A

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:3080587

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin

object_name: ankylosing spondylitis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:MF4P7VQ2K8

subject_name: TAVOKINOGENE TELSEPLASMID

object_name: triple-negative breast carcinoma


subject: UNII:MF4P7VQ2K8

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:9123

subject_name: Sertraline

object_name: pervasive developmental disorder


subject: CHEBI:9123

object_name: autism


subject: CHEBI:9123

object_name: autism spectrum disorder


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: prostate carcinoma


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0139121

subject_name: SDZ PSC 833

object_name: Childhood Breast Carcinoma


subject: UMLS:C0139121

object_name: breast carcinoma


subject: UMLS:C0139121

object_name: breast cancer


subject: UMLS:C0139121

object_name: Neoplasm Metastasis


subject: UMLS:C0139121

object_name: ovarian cancer


subject: UMLS:C0139121

object_name: ovarian neoplasm


subject: UMLS:C0139121

object_name: ovarian carcinoma


subject: UMLS:C0139121

object_name: kidney neoplasm


subject: UMLS:C0139121

object_name: childhood kidney neoplasm


subject: UMLS:C0139121

object_name: adult lymphoma


subject: UMLS:C0139121

object_name: lymphoma


subject: UMLS:C0139121

object_name: pediatric lymphoma


subject: CHEBI:16811

subject_name: Racemethionine

object_name: bone marrow disorder


subject: CHEBI:16811

object_name: spinal cord disorder


subject: CHEBI:16811

object_name: Myelopathy


subject: CHEBI:16811

object_name: Myelopathy with AIDS (acquired immunodeficiency syndrome)


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: UMLS:C0034504


subject: CHEBI:23965

subject_name: estradiol

object_name: Endometriosis related pain


subject: PUBCHEM.COMPOUND:541197

subject_name: Norethindrone acetate


subject: CHEBI:7627

subject_name: Norethisterone


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:114785

object_name: Embolism, Tumor


subject: CHEBI:114785


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Locally advanced breast cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F